Company Quick10K Filing
HB Fuller
10-Q 2021-02-27 Filed 2021-03-25
10-K 2020-11-28 Filed 2021-01-26
10-Q 2020-08-29 Filed 2020-09-24
10-Q 2020-05-30 Filed 2020-06-25
10-Q 2020-02-29 Filed 2020-03-26
10-K 2019-11-30 Filed 2020-01-24
10-Q 2019-08-31 Filed 2019-09-27
10-Q 2019-06-01 Filed 2019-06-28
10-Q 2019-03-02 Filed 2019-03-29
10-K 2018-12-01 Filed 2019-01-28
10-Q 2018-09-01 Filed 2018-09-28
10-Q 2018-06-02 Filed 2018-06-29
10-Q 2018-03-03 Filed 2018-04-04
10-K 2017-12-02 Filed 2018-01-31
10-Q 2017-09-02 Filed 2017-09-29
10-Q 2017-06-03 Filed 2017-06-30
10-Q 2017-03-04 Filed 2017-03-31
10-K 2016-12-03 Filed 2017-01-31
10-Q 2016-08-27 Filed 2016-09-23
10-Q 2016-05-28 Filed 2016-06-24
10-Q 2016-02-27 Filed 2016-04-05
10-K 2015-11-28 Filed 2016-01-27
10-Q 2015-08-29 Filed 2015-09-25
10-Q 2015-05-30 Filed 2015-06-30
10-Q 2015-02-28 Filed 2015-03-27
10-K 2014-11-29 Filed 2015-01-28
10-Q 2014-08-30 Filed 2014-09-26
10-Q 2014-05-31 Filed 2014-06-27
10-Q 2014-03-01 Filed 2014-03-28
10-K 2013-11-30 Filed 2014-01-24
10-Q 2013-08-31 Filed 2013-09-27
10-Q 2013-06-01 Filed 2013-06-28
10-Q 2013-03-02 Filed 2013-03-29
10-K 2012-12-01 Filed 2013-01-29
10-Q 2012-09-01 Filed 2012-10-05
10-Q 2012-06-02 Filed 2012-07-06
10-Q 2012-03-03 Filed 2012-03-30
10-K 2011-12-03 Filed 2012-01-27
10-Q 2011-08-27 Filed 2011-09-23
10-Q 2011-05-28 Filed 2011-06-24
10-Q 2011-02-26 Filed 2011-03-28
10-K 2010-11-27 Filed 2011-01-20
10-Q 2010-08-28 Filed 2010-09-30
10-Q 2010-05-29 Filed 2010-06-30
10-Q 2010-02-27 Filed 2010-03-31
10-K 2009-11-28 Filed 2010-01-22
8-K 2021-01-25 Earnings, Exhibits
8-K 2021-01-21 Exhibits
8-K 2020-11-30 Exhibits
8-K 2020-10-20
8-K 2020-10-07
8-K 2020-09-23
8-K 2020-06-24
8-K 2020-04-02
8-K 2020-03-25
8-K 2020-03-04
8-K 2020-01-22
8-K 2020-01-15
8-K 2019-11-13
8-K 2019-09-25
8-K 2019-07-16
8-K 2019-07-02
8-K 2019-06-26
8-K 2019-06-11
8-K 2019-04-23
8-K 2019-04-04
8-K 2019-03-27
8-K 2019-03-25
8-K 2019-01-24
8-K 2019-01-16
8-K 2018-09-26
8-K 2018-07-18
8-K 2018-07-11
8-K 2018-06-27
8-K 2018-04-12
8-K 2018-03-28
8-K 2018-03-27
8-K 2018-02-26
8-K 2018-01-23

HB Fuller Financials

FUL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-08-282010-11-272011-02-262011-05-282011-08-272011-12-032012-03-032012-06-022012-09-012012-12-012013-03-022013-06-012013-08-312013-11-302014-03-012014-05-312014-08-302014-11-292015-02-282015-05-302015-08-292015-11-282016-02-272016-05-282016-08-272016-12-032017-03-042017-06-032017-09-022017-12-022018-03-032018-06-022018-09-012018-12-012019-03-022019-06-01
Cash1411331221381491561501542082001631611601551139507872798611912714613314211794120194132129150151113100
Accounts Receivable2092212272452422442453153193203083173193313273540341336356342365335355344351358379393474467478466486478499
Inventory1481221441521731361632122162092292222212222612820251275266267249265261261247286302318360410405401356387383
PP&E7972518218388488388408748869089229439871,0331,0691,10011,1061,1341,1291,1301,1121,1281,1441,1561,0931,0861,1111,1361,2881,3161,2961,2951,3041,3221,323
Assets1,1791,1531,1741,2501,2861,2281,2561,7351,7481,7861,7651,7741,8001,8731,9091,96121,8692,0972,0912,0692,0422,0232,0672,0802,0582,1692,2002,2884,3614,3744,3394,2904,1754,1664,150
Accounts Payable1191021231341391161361731631631681671692022082220174195192171178163162161163181182193268257264256273285300
Long-Term Debt2145625156067166866796756938217928342,4522,3992,3562,2922,2332,1322,131
Liabilities5795195075265335185241,0309501,0049619539569389701,00119741,2261,1961,1601,1651,1341,1381,1191,1161,2201,2081,2563,3173,2543,2093,1623,0232,9922,987
Stockholders' Equity59763266572274670572870179377880081684093093495418908668889048738859249569389499911,0321,0441,1201,1301,1281,1521,1741,163
Income Statement ($MM)2010-08-282010-11-272011-02-262011-05-282011-08-272011-12-032012-03-032012-06-022012-09-012012-12-012013-03-022013-06-012013-08-312013-11-302014-03-012014-05-312014-08-302014-11-292015-02-282015-05-302015-08-292015-11-282016-02-272016-05-282016-08-272016-12-032017-03-042017-06-032017-09-022017-12-022018-03-032018-06-022018-09-012018-12-012019-03-022019-06-01
Revenue3393603403953884373755275015134805195155344865441548471541524548474533513575503562563678713789770768673760
Cost of Revenue242258243282276311261390366370346372370388353401015354392377392337374367407364416412510525567553559493541
Gross Profit96102971131121261141371341441331471451461331430533116149147156138158146168139146150168188222217210180218
R&D
SG&A7473767880858393919598949193971030383951019810410010498106113103110151151145146140146146
Tax4-11610105939291211121279034515142191413157119-1710139916
Net Income19221425232615283252126282215210501025272519333339152625-8484438411237
Cash Flow ($MM)2010-08-282010-11-272011-02-262011-05-282011-08-272011-12-032012-03-032012-06-022012-09-012012-12-012013-03-022013-06-012013-08-312013-11-302014-03-012014-05-312014-08-302014-11-292015-02-282015-05-302015-08-292015-11-282016-02-272016-05-282016-08-272016-12-032017-03-042017-06-032017-09-022017-12-022018-03-032018-06-022018-09-012018-12-012019-03-022019-06-01
Cash Operating4713228403323143-11524843-17-173430665037574340635016163870-325484077
Cash Investing-12-6-14-7-11-5-412-5-25-18-31-43-41-50-3080-160-245-11-96-22-21-52-15-144-6-9-1,642-17-13-11-14-28
Cash Financing-48-11-8-9-15-4385-91-16-9-22-8-102530-5555176-30-14-27-130-19-21102-33-71,649-15-42-46-27-60